Press Releases

Huateng Pharma Announced To Attend INTERPEHX Week Tokyo - in-PHARMA JAPAN In July 2023

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.

Amerigo Scientific Launches Ultra Low Temperature Freezers (-40°C to -86°C) for Lab Sample Storage

Amerigo Scientific launches its ultra-low temperature freezers with a temperature range from -40°C to -86°C.

CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023

CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023 CluePoints and partners present and discuss the results of a new study examining RBQM use and adoption.

Alfa Chemistry Commenced Offering Nonlinear Crystals and Precision Optical Materials

Packaging Solutions Ensuring Product Integrity: Glass and Plastic Varieties

Alfa Chemistry: Test Kits Provides New Options to Transform Testing Strategy

Creative Proteomics Launches Crotonylation Proteomics Analysis Service to Enhance Your Epigenetic Research

Creative Proteomics Revolutionizes DNA-Protein Interaction Studies with Cutting-Edge DNA Pull Down Service

Creative Proteomics Expands Proteomics Services with Launch of N-Terminal Edman Degradation Service

Creative Biolabs' Exhibition at BIO 2023 Accomplished

Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.

PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics

PrecisionLife and Nanopharmaceutics, Inc. has announced today a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system assets.

BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory

BullFrog AI Holdings, Inc. announced the expansion of its worldwide license agreement with the Johns Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, for use of patented technology powering the Company’s bfLEAP™ platform, an AI-driven platform for analyzing drug development data to potentially make life-saving therapies and treatments available to patients more quickly.

MIB Agents’ Community of Families Has Awarded Over $1.5M in Grants to Research Pediatric Bone Cancer

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.

Breaking Barriers in Clinical Trials: AI and Automation as a Catalyst for Innovation

This article highlights how AI and automation are driving innovation in clinical trial research by improving patient outcomes, reducing costs, and overcoming traditional barriers to progress.

AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio

AntlerA Therapeutics has announced a strategic collaboration and licensing agreement with EyeBio to begin clinical testing of AntlerA's Norrin/Wnt-agonist, a treatment of leaky blood vessels in the eye.

SMi discloses £6 million seed funding round, bolsters team with new C-suite hire

SMi Systems has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.

Unique molecule life cycle platform released: Torx® 2.0

Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.

Sygnature Discovery launches its LPS in vivo model to profile early-stage anti-inflammatory drugs

Inizio Prioritizes Medical Excellence and Transformation with New Senior Appointment

Inizio Medical has announced a top-level hire in its senior leadership team, with the appointment of Shauna Aherne as President of Medical Excellence, Specialized Services.

CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research